Solace Therapeutics is an emerging medical device company focused on the development of non-surgical office based treatments for common bladder disorders, such as stress urinary incontinence (SUI), Solace is dedicated to improving the patient’s quality of life by eliminating side effects typically associated with current drug and surgical therapies. Solace’s proprietary technology is designed to offer patients the following benefits: Office-based therapy that does not require anesthesia or surgery No lifestyle change required, before or after treatment Reversible at any time
| Website | http://www.solacetx.com |
| Revenue | $4 million |
| Employees | 7 (0 on RocketReach) |
| Founded | 1997 |
| Address | 135 Newbury Street, Framingham, Massachusetts 01701, US |
| Phone | +1 508-283-1200 |
| Fax | (214) 522-4650 |
| Technologies |
JavaScript
,
HTML
,
Google Analytics
+14 more
(view full list)
|
| Industry | Medical Devices, Manufacturing General, Health Care, Therapeutic Devices, Manufacturing, Medical Device, Other Healthcare Technology Systems, Therapeutics |
| Web Rank | 14 Million |
| Keywords | Bladder Health, Non-Invasive Treatments, Non Surgical Treatments, Urology, Incontinence Treatment, Pelvic Floor, Minimally Invasive, Medical Technology, Urogynecology, Health Technology, Patient Care, Surgical Alternatives, Treatment Options, Quality Of Life |
| Competitors | Medtronic, Hologic, Inc., Revance, Actavis plc (now Allergan), Merz Group, Sientra, Inc., Inspira Health, NEOFECT, MediSprout +32 more (view full list) |
| SIC | SIC Code 384 Companies, SIC Code 38 Companies |
| NAICS | NAICS Code 339 Companies, NAICS Code 33 Companies |
Looking for a particular Solace Therapeutics employee's phone or email?
Solace Therapeutics Questions
The Solace Therapeutics annual revenue was $4 million in 2026.
Solace Therapeutics is based in Framingham, Massachusetts.
The NAICS codes for Solace Therapeutics are [339, 33].
The SIC codes for Solace Therapeutics are [384, 38].
Related Companies
